Protein ADP-Ribosylation

Loading

  • Protein ADP-ribosylation is an important post-translational modification (PTM) in which an ADP-ribose group is transferred from NAD+ to a target protein or, in some cases, to other cellular molecules. This modification plays major roles in DNA damage responses, DNA repair, chromatin regulation, transcription, cell signaling, metabolism, inflammation, stress responses, and cell death. ADP-ribosylation is a highly versatile modification because it can occur as a single ADP-ribose group or as chains of ADP-ribose units.
  • The donor molecule for ADP-ribosylation is nicotinamide adenine dinucleotide (NAD+), an essential cellular metabolite involved in energy metabolism and redox reactions. ADP-ribosyltransferase enzymes cleave NAD+ and transfer the ADP-ribose portion to specific target molecules while releasing nicotinamide.
  • ADP-ribosylation can be broadly divided into mono-ADP-ribosylation (MARylation) and poly-ADP-ribosylation (PARylation). Mono-ADP-ribosylation attaches a single ADP-ribose unit to a target, whereas poly-ADP-ribosylation involves the synthesis of linear or branched chains containing multiple ADP-ribose units.
  • The enzymes responsible for these reactions are generally known as ADP-ribosyltransferases (ARTs). In humans, the ADP-ribosyltransferase family includes several proteins with different substrate preferences, cellular locations, and biological functions.
  • A major group of enzymes involved in poly-ADP-ribosylation is the poly(ADP-ribose) polymerase (PARP) family. PARP proteins are particularly well known for their roles in detecting DNA damage and coordinating DNA repair.
  • Although the name PARP suggests that these enzymes primarily produce poly(ADP-ribose), individual PARP family members can have different activities. Some primarily produce poly-ADP-ribose, whereas others are predominantly mono-ADP-ribosyltransferases.
  • The best-known enzyme in this family is PARP1, a nuclear protein that responds rapidly to DNA damage. PARP1 detects damaged DNA structures and becomes activated, leading to the synthesis of poly(ADP-ribose) on itself and other nuclear proteins.
  • PARP1 contains domains that recognize DNA damage, including single-strand breaks and other abnormal DNA structures. Once activated, PARP1 uses NAD+ to synthesize poly(ADP-ribose) (PAR).
  • PARP1-mediated PARylation is an important component of the DNA damage response. The negatively charged PAR polymer can recruit DNA repair proteins and alter the local chromatin environment around damaged DNA.
  • Another important enzyme is PARP2, which also participates in DNA damage responses and can contribute to PAR formation. PARP2 has overlapping but distinct functions compared with PARP1.
  • Other PARP family members participate in processes such as transcriptional regulation, chromatin organization, cellular stress responses, and protein modification. The broader PARP family therefore represents a diverse regulatory system rather than a single DNA repair pathway.
  • ADP-ribosylation can occur on several amino acid residues. Common targets include glutamate, aspartate, serine, lysine, arginine, cysteine, and tyrosine, although the preferred target can vary depending on the enzyme and biological context.
  • The chemistry of ADP-ribosylation is particularly important because the modification can create different molecular structures depending on the target amino acid and the type of ADP-ribose linkage formed.
  • Serine ADP-ribosylation has received significant attention because it is an important feature of PARP1- and PARP2-dependent DNA damage signaling. The modification can recruit and regulate downstream DNA repair factors.
  • ADP-ribosylation can also occur on histones and other chromatin-associated proteins. Modification of these proteins can change chromatin organization and influence the accessibility of DNA to repair and transcription machinery.
  • The relationship between ADP-ribosylation and chromatin remodeling is therefore an important aspect of its biology. PAR chains can alter electrostatic interactions and recruit proteins containing PAR-binding domains.
  • ADP-ribose and PAR can serve as molecular signals that recruit proteins through specialized ADP-ribose-binding domains and PAR-binding domains. These domains allow proteins to recognize ADP-ribosylated targets and participate in downstream pathways.
  • One important class of PAR-binding proteins contains macrodomain-containing proteins. Macrodomains can recognize ADP-ribose or related metabolites and, in some cases, remove ADP-ribose from modified proteins.
  • The existence of enzymes that both add and remove ADP-ribose makes ADP-ribosylation a dynamic and reversible PTM. This allows cells to rapidly control signaling pathways in response to changes in cellular conditions.
  • Important enzymes involved in removing ADP-ribose include PARG (poly(ADP-ribose) glycohydrolase) and several ADP-ribose hydrolases. PARG primarily degrades poly-ADP-ribose chains, whereas other hydrolases can remove ADP-ribose from specific amino acid residues.
  • The balance between PAR synthesis and PAR degradation determines the duration and intensity of ADP-ribosylation signaling. This balance is essential because excessive PAR accumulation can contribute to cellular toxicity.
  • ADP-ribosylation is strongly connected to DNA repair. When DNA damage occurs, PARP enzymes can rapidly accumulate at damaged DNA and produce PAR, creating a temporary molecular platform for recruitment of repair proteins.
  • PARylation can facilitate the recruitment of proteins involved in single-strand break repair, base excision repair, replication stress responses, and chromatin remodeling.
  • One of the major DNA repair pathways influenced by PARP activity is base excision repair, which repairs damaged individual DNA bases and associated single-strand DNA lesions.
  • PARP-dependent signaling is also important in the response to single-strand DNA breaks. PARP1 activation can help coordinate repair factors at the damaged site and influence chromatin accessibility.
  • ADP-ribosylation is closely connected to DNA replication. Replication forks can encounter DNA lesions and other forms of replication stress, and PARP-dependent signaling can help cells respond to these problems.
  • PARP proteins also participate in replication fork protection and restart. Their activities can influence how stalled replication machinery is stabilized or processed.
  • The importance of PARP-mediated DNA repair has led to the development of PARP inhibitors, an important class of targeted cancer therapies. These drugs interfere with PARP catalytic activity and, depending on the drug and cellular context, can also influence the trapping of PARP proteins on DNA.
  • PARP inhibitors are particularly effective in some tumors with defects in homologous recombination repair (HRR). A well-known example involves cancers with defects in the BRCA1 or BRCA2 genes.
  • The therapeutic concept is based on synthetic lethality. If a cancer cell already has a defect in one DNA repair pathway, inhibiting another repair pathway can create a level of DNA damage that the cell cannot tolerate.
  • This relationship between PARP inhibition and BRCA deficiency has become an important example of precision medicine and targeted cancer therapy.
  • However, PARP biology extends beyond cancer therapy. ADP-ribosylation participates in normal cellular processes including transcription, metabolism, immune signaling, stress responses, and cell death.
  • ADP-ribosylation is also important in transcriptional regulation. PARP proteins can modify transcription factors, chromatin-associated proteins, and other regulators of gene expression.
  • PAR chains can alter chromatin structure and recruit proteins involved in transcription. Through these mechanisms, ADP-ribosylation can influence which regions of the genome are accessible to transcription machinery.
  • ADP-ribosylation can also regulate chromatin architecture. Histone modification by ADP-ribose can influence interactions between histones and DNA and can contribute to changes in chromatin compaction.
  • The relationship between ADP-ribosylation and epigenetic regulation is therefore an important area of research. Although ADP-ribosylation is not traditionally classified as a classical epigenetic mark, it can influence epigenetic proteins and chromatin states.
  • ADP-ribosylation also participates in cellular stress responses. DNA damage, oxidative stress, replication stress, and other forms of cellular injury can activate PARP-dependent signaling.
  • Because PARP enzymes consume NAD+, extensive PARP activation can significantly affect cellular NAD+ metabolism. Severe DNA damage can therefore create a connection between DNA repair signaling and cellular energy metabolism.
  • Excessive PARP activation can deplete NAD+ and ATP, particularly when DNA damage is severe and persistent. This can contribute to a form of regulated cell death known as parthanatos.
  • Parthanatos is associated with extensive PAR accumulation, mitochondrial dysfunction, release of apoptosis-inducing factor, and large-scale cellular energy disruption. It is distinct from classical apoptosis, although the pathways can interact.
  • ADP-ribosylation can therefore have both protective and harmful effects. Moderate PARP activation can promote DNA repair and cell survival, whereas excessive activation can contribute to cell death.
  • This illustrates the importance of PARP activation dynamics. The biological outcome depends on the amount and duration of DNA damage, the level of PAR synthesis, cellular NAD+ availability, and the ability to remove PAR.
  • ADP-ribosylation is also important in inflammation and immune signaling. PARP proteins can influence inflammatory transcription factors and signaling pathways, while mono-ADP-ribosyltransferases can modify proteins involved in immune responses.
  • Several ART family members participate in immune-cell signaling and host defense. ADP-ribosylation can influence cytokine responses, transcriptional programs, cellular metabolism, and interactions between immune cells.
  • ADP-ribosylation also has an important role in innate immunity. Some immune-related proteins use ADP-ribosylation to modify host or pathogen-associated molecules.
  • Certain pathogens have evolved mechanisms that interfere with ADP-ribosylation. Some bacterial toxins, for example, are themselves ADP-ribosylating toxins that modify host proteins and disrupt normal cellular signaling.
  • Important examples include bacterial toxins that modify G proteins, elongation factors, and other cellular proteins. These toxins demonstrate how ADP-ribosylation can be used as a mechanism for manipulating host-cell physiology.
  • Diphtheria toxin is a classic example. It ADP-ribosylates elongation factor 2, disrupting protein synthesis and leading to cellular toxicity.
  • Cholera toxin provides another well-known example. It ADP-ribosylates the Gs alpha subunit of a heterotrimeric G protein, causing persistent activation of adenylate cyclase signaling and contributing to the characteristic effects of cholera infection.
  • These bacterial toxins demonstrate that ADP-ribosylation can have powerful effects on cellular signaling and protein function.
  • Host cells have evolved mechanisms to detect and respond to abnormal ADP-ribosylation. Certain ADP-ribose hydrolases and macrodomain proteins can remove toxin-induced modifications or regulate endogenous ADP-ribose signaling.
  • Macrodomains are therefore important not only for recognizing ADP-ribose but also for regulating the duration of ADP-ribosylation signals.
  • ADP-ribosylation also plays a role in protein trafficking and cellular compartmentalization. Different ART enzymes are located in different cellular compartments, including the nucleus, cytoplasm, mitochondria, Golgi apparatus, and cell surface.
  • This spatial distribution allows ADP-ribosylation to regulate different processes depending on where the modification occurs.
  • Some mono-ADP-ribosyltransferases are associated with the plasma membrane and extracellular environment. These enzymes can modify cell-surface proteins and contribute to cell–cell communication and immune regulation.
  • ADP-ribosylation is also connected to mitochondrial biology. Several PARP family proteins and related enzymes influence mitochondrial function, while excessive PARP activation can affect mitochondrial metabolism through NAD+ depletion and stress signaling.
  • The connection between ADP-ribosylation and metabolism is particularly important because NAD+ is both a metabolic cofactor and the substrate for PARP-mediated ADP-ribosylation.
  • This creates a direct link between NAD+ metabolism and protein modification. Cellular changes in NAD+ availability can influence the capacity for ADP-ribosylation, while extensive PARP activity can consume NAD+.
  • NAD+ metabolism also intersects with other regulatory pathways involving sirtuins, which use NAD+ to catalyze deacylation reactions. PARPs and sirtuins therefore compete, under some conditions, for a shared metabolic resource.
  • This relationship illustrates how metabolic state and post-translational modification can influence one another.
  • ADP-ribosylation can also participate in protein degradation and proteostasis. Modification of proteins can influence interactions with protein quality-control machinery and affect their localization or turnover.
  • The relationship between PARP signaling and ubiquitination is particularly important. DNA damage responses involve extensive coordination between ADP-ribosylation, ubiquitination, phosphorylation, and other PTMs.
  • ADP-ribosylation and phosphorylation can act together during the DNA damage response. Kinases and PARPs can be activated by related stress signals, and their modifications can create complementary molecular signals for recruiting repair proteins.
  • ADP-ribosylation can also interact with SUMOylation and ubiquitination. Chromatin-associated proteins may undergo multiple modifications that collectively regulate DNA repair and transcription.
  • This extensive PTM crosstalk allows cells to integrate different types of molecular information and generate coordinated responses to cellular stress.
  • ADP-ribosylation is also relevant to cellular senescence. Persistent DNA damage and altered NAD+ metabolism can activate PARP-dependent pathways, while changes in ADP-ribosylation may contribute to long-term changes in cellular function.
  • In aging, alterations in DNA damage, NAD+ metabolism, mitochondrial function, and PARP activity can influence cellular homeostasis. Changes in the balance between PAR synthesis and degradation may therefore contribute to age-related cellular dysfunction.
  • ADP-ribosylation has also been investigated in neurobiology. PARP activity participates in neuronal responses to DNA damage, oxidative stress, excitotoxicity, and other forms of cellular injury.
  • Excessive PARP activation in neurons can contribute to NAD+ depletion, mitochondrial dysfunction, and cell death. This has led to interest in PARP signaling in neurological injury and neurodegenerative disorders.
  • ADP-ribosylation is also relevant to ischemia-reperfusion injury. Severe DNA damage and oxidative stress during ischemia and subsequent reperfusion can activate PARP enzymes.
  • Excessive PARP activation can worsen energy depletion and contribute to tissue damage. Consequently, PARP signaling has been investigated as a potential therapeutic target in several forms of acute tissue injury.
  • ADP-ribosylation also participates in cardiovascular biology. PARP signaling can influence oxidative stress, inflammation, endothelial function, vascular responses, and cardiac cellular stress.
  • In metabolic disease, altered NAD+ metabolism and cellular stress can influence PARP activity. Conversely, excessive PARP activation can consume NAD+ and affect metabolic homeostasis.
  • The connection between NAD+ metabolism, PARP activity, and metabolic health has become an important area of research.
  • ADP-ribosylation also has important implications for cancer biology beyond the clinical use of PARP inhibitors. Tumor cells frequently experience replication stress, DNA damage, altered metabolism, and oxidative stress, all of which can affect ADP-ribosylation pathways.
  • Cancer cells may become particularly dependent on specific DNA repair pathways. This creates opportunities to target ADP-ribosylation enzymes therapeutically.
  • PARP inhibitors are now used in selected cancers, while researchers are investigating inhibitors of additional PARP family members and other components of the ADP-ribose signaling network.
  • Resistance to PARP inhibitors can develop through multiple mechanisms, including restoration of homologous recombination repair, changes in DNA replication, alterations in drug transport, and changes in PARP1 function.
  • Understanding PARP inhibitor resistance is therefore an important area of cancer research.
  • ADP-ribosylation is also relevant to drug development because PARP enzymes contain catalytic domains that can be targeted by small molecules. Structural studies have helped reveal how PARP inhibitors bind their target proteins.
  • Another important concept is PARP trapping. Some PARP inhibitors can stabilize PARP proteins on DNA lesions, creating persistent protein–DNA complexes that interfere with DNA replication and repair.
  • PARP trapping contributes to the cytotoxic effects of some inhibitors and helps explain why different PARP inhibitors can have different biological properties despite targeting related enzymes.
  • ADP-ribosylation can also regulate DNA replication fork stability. PARP-dependent signaling helps cells respond when replication machinery encounters DNA damage or structural obstacles.
  • The interaction between PARP signaling and replication stress is especially important in cancer cells because many tumors experience high levels of replication-associated stress.
  • ADP-ribosylation is also connected to chromosome stability. Efficient DNA repair and replication control help prevent mutations, chromosome rearrangements, and genomic instability.
  • Loss or dysregulation of ADP-ribosylation pathways can therefore influence genome stability and disease development.
  • The study of ADP-ribosylation has been greatly advanced by mass spectrometry-based proteomics. Modern techniques can identify ADP-ribosylated proteins and, in some cases, determine the specific amino acid residues carrying the modification.
  • However, ADP-ribose can be chemically labile and structurally complex, making site-specific analysis challenging. Specialized enrichment, digestion, fragmentation, and computational methods are therefore used.
  • ADP-ribosylation proteomics can reveal large numbers of modified proteins and help identify biological pathways regulated by the modification.
  • The term ADP-ribosylome can be used to describe the collection of ADP-ribosylated proteins and modification sites in a biological system.
  • Advanced mass spectrometry methods can distinguish between mono-ADP-ribosylation and poly-ADP-ribosylation and can provide information about the structure and length of PAR chains.
  • PAR chain analysis is important because the biological properties of PAR depend on its length, branching, abundance, and attachment to proteins.
  • PAR can also interact with nucleic acids and proteins through electrostatic and domain-mediated interactions. These interactions contribute to the formation of temporary molecular assemblies at sites of DNA damage.
  • One emerging area is the relationship between PAR and biomolecular condensates. PAR can contribute to the formation or organization of dynamic cellular assemblies involved in stress responses and DNA repair.
  • ADP-ribosylation can therefore influence not only individual protein activity but also the organization of proteins within cellular compartments.
  • Another important research area is ADP-ribose metabolism. Cells contain enzymes that synthesize, degrade, and recycle ADP-ribose and related metabolites.
  • The breakdown of PAR produces ADP-ribose and other products that can enter cellular metabolic pathways. Thus, ADP-ribosylation is connected to broader NAD+ and nucleotide metabolism.
  • The interaction between ADP-ribosylation and NAD+ homeostasis is especially important under conditions of DNA damage. High PARP activity can consume substantial amounts of NAD+, potentially affecting other NAD+-dependent enzymes.
  • This provides a direct molecular connection between DNA damage, metabolism, and cell survival.
  • ADP-ribosylation is also important in DNA repair pathway choice. PARP-dependent signaling can influence the recruitment and activity of different repair proteins and help determine how cells respond to specific DNA lesions.
  • The modification can also regulate chromatin accessibility around damaged DNA, allowing repair proteins to access DNA while later facilitating restoration of chromatin structure.
  • ADP-ribosylation therefore acts as both a biochemical modification and a molecular recruitment signal.
  • The dynamic nature of ADP-ribosylation is controlled by a balance between writer enzymes, reader proteins, and eraser enzymes. Writers add ADP-ribose, readers recognize the modification, and erasers remove it.
  • This writer–reader–eraser framework provides a useful way to understand ADP-ribosylation as a signaling system.
  • Important ADP-ribose readers include proteins containing macrodomains, PAR-binding motifs, WWE domains, and other recognition modules. These proteins translate the presence of ADP-ribose into downstream biological responses.
  • The discovery of diverse ADP-ribose readers has expanded our understanding of how this modification controls complex cellular pathways.
  • ADP-ribosylation also demonstrates extensive protein modification crosstalk. A single protein may undergo ADP-ribosylation together with phosphorylation, ubiquitination, SUMOylation, acetylation, methylation, glycosylation, nitrosylation, or other modifications.
  • These combinations can determine protein localization, stability, activity, and interaction with other molecules.
  • The relationship between ADP-ribosylation and protein phosphorylation is especially important in DNA damage signaling. Phosphorylation and PARylation can occur sequentially or simultaneously to create coordinated repair responses.
  • ADP-ribosylation can also influence ubiquitin signaling. Ubiquitination of proteins at damaged chromatin and PAR-dependent recruitment of repair factors are closely integrated processes.
  • Similarly, SUMOylation participates in DNA repair and chromatin regulation, creating additional layers of PTM crosstalk.
  • ADP-ribosylation therefore belongs to a larger network of protein modifications that collectively regulate cellular responses.
  • In addition to proteins, ADP-ribosylation can modify nucleic acids and small molecules in certain biological contexts. These reactions further expand the functional range of ADP-ribose signaling.
  • ADP-ribosylation of DNA and RNA has emerged as an area of active research, although protein ADP-ribosylation remains the best-established and most extensively characterized form.
  • The ability to modify different molecular targets suggests that ADP-ribose can function as a broader cellular signaling metabolite rather than simply as a conventional protein PTM.
  • The study of ADP-ribosylation has also revealed important links between DNA damage, metabolism, inflammation, immunity, and cell death. These pathways were once studied separately but are increasingly understood as interconnected systems.
  • Future research will continue to investigate the substrate specificity of individual ART enzymes, the functions of different PARP family members, the recognition of ADP-ribose by reader proteins, and the mechanisms that remove the modification.
  • Researchers are also developing new ADP-ribosylation inhibitors, activators, probes, and imaging tools. These technologies can help determine where and when ADP-ribosylation occurs within living cells.
  • Chemical biology approaches are particularly valuable because they can allow researchers to manipulate individual ADP-ribosylation enzymes and investigate their functions with greater specificity.
  • Improved ADP-ribosylation proteomics will also help identify modification sites and distinguish functional ADP-ribosylation from incidental or stress-associated modification.
  • Understanding the spatial and temporal regulation of ADP-ribosylation will be especially important. The same enzyme can have different effects depending on its cellular location, substrate availability, activation state, and interaction partners.
  • In conclusion, ADP-ribosylation is a versatile post-translational modification in which ADP-ribose is transferred from NAD+ to target molecules. It includes mono-ADP-ribosylation and poly-ADP-ribosylation, with PARP enzymes playing central roles in many cellular processes.
  • ADP-ribosylation is particularly important in the DNA damage response and DNA repair, where PARP1 and related enzymes detect DNA lesions, generate PAR, modify nuclear proteins, and recruit repair machinery.
  • The modification also regulates chromatin organization, transcription, replication, metabolism, inflammation, immunity, mitochondrial function, stress responses, and cell death.
  • The balance between ADP-ribose synthesis and removal is controlled by ADP-ribosyltransferases, PARP enzymes, PARG, ADP-ribose hydrolases, and other regulatory proteins.
  • ADP-ribose is recognized by specialized reader proteins, including macrodomain-containing proteins and PAR-binding proteins. These readers convert ADP-ribosylation into downstream cellular responses.
  • The use of NAD+ as the substrate creates a direct connection between ADP-ribosylation and NAD+ metabolism. Extensive PARP activation can consume NAD+ and ATP, linking DNA damage to cellular energy balance and, under severe conditions, to parthanatos.
  • ADP-ribosylation is also important in cancer biology, particularly because defects in DNA repair can make cancer cells sensitive to PARP inhibition. The relationship between PARP inhibitors, BRCA deficiency, homologous recombination repair, synthetic lethality, and PARP trapping has become a major area of therapeutic research.
  • ADP-ribosylation also plays important roles in immune responses, inflammation, neurobiology, aging, cardiovascular biology, metabolic disease, and host–pathogen interactions.
  • The discovery of bacterial ADP-ribosylating toxins has demonstrated how powerful this modification can be in altering host-cell physiology. At the same time, endogenous ADP-ribosylation provides essential regulatory functions within normal cells.
  • Modern mass spectrometry, ADP-ribosylation proteomics, structural biology, chemical biology, imaging, and computational approaches are revealing the complexity of this modification and identifying new ADP-ribosylated proteins and signaling pathways.
  • Overall, ADP-ribosylation can be viewed as a molecular bridge connecting NAD+ metabolism, DNA repair, chromatin biology, cellular stress, protein regulation, immune signaling, and cell fate. Understanding how ADP-ribosylation is written, read, and erased will continue to provide important insights into normal cellular physiology and human disease.
Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *